May 25,2023
Announcement no. 32
Managers’ transactions
Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in Pharma Equity Group A/S made by persons discharging managerial responsibilities in Pharma Equity Group and/or persons closely related with them.
| 1. Details of the person discharging managerial responsibilities/person closely associated |
|
| a) Name | Thomas Kaas Selsø |
| 2. Reason for the notification | |
| a) Position/status | CEO |
| b) Initial notification/amendment |
Initial notification |
| 3. Details of the issuer |
|
| a) Name |
Pharma Equity Group A/S |
| b) LEI |
2138008SUI4D917FKN20 |
| c) Trade name |
PEG |
| 4. Details of the transaction(s) |
|
| a) Description of the financial instrument, type of instrument and Identification code |
Shares, ISIN code DK0061155009 |
| b) Nature of the transaction |
Purchase |
| c) Price(s) and volume(s) |
Price: DKK 167,225
Volume: 551,724 |
| d) Aggregated information – Aggregated volume – Aggregated price |
N/A |
| e) Date of the transaction |
25-05-2023, 09:26 CEST |
| f) Place of the transaction |
Nasdaq Copenhagen A/S |
For further information, please contact:
Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14
Peter M. Eriksen, Chair of the Board of Directors of Pharma Equity Group A/S, phone: 51 99 66 00.
